Trevi Therapeutics, Inc. · NASDAQ:TRVI
BlackRock, Inc. reported a 5.60% stake in Trevi Therapeutics, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Oct 17, 2025
BlackRock, Inc. reported a 5.60% stake in Trevi Therapeutics, Inc., 6,804,338 shares, as a passive investor on Sep 30, 2025. Filed Oct 17, 2025 (Schedule 13G).
- Stake
- 5.60%
- Shares
- 6,804,338
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.60% | 6,804,338 |
Source
Related
- Trevi Therapeutics, Inc.
- BlackRock, Inc.
- Trevi Therapeutics, Inc. shareholders
- Form 4 · Heffernan Michael Thomas · Sep 17, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13D/A · New Enterprise Associates 16, L.P. · May 7, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026